These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 30919595)
21. Expression of programmed death 1 ligands by murine T cells and APC. Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930 [TBL] [Abstract][Full Text] [Related]
22. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Scheinecker C; Zwölfer B; Köller M; Männer G; Smolen JS Arthritis Rheum; 2001 Apr; 44(4):856-65. PubMed ID: 11315925 [TBL] [Abstract][Full Text] [Related]
23. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1. Patera AC; Drewry AM; Chang K; Beiter ER; Osborne D; Hotchkiss RS J Leukoc Biol; 2016 Dec; 100(6):1239-1254. PubMed ID: 27671246 [TBL] [Abstract][Full Text] [Related]
24. Expanded circulating peripheral helper T cells in systemic lupus erythematosus: association with disease activity and B cell differentiation. Makiyama A; Chiba A; Noto D; Murayama G; Yamaji K; Tamura N; Miyake S Rheumatology (Oxford); 2019 Oct; 58(10):1861-1869. PubMed ID: 30879065 [TBL] [Abstract][Full Text] [Related]
25. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells. Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515 [TBL] [Abstract][Full Text] [Related]
26. The immunoregulatory axis (programmed death-1/programmed death ligand-1) on CD4+ T cells in lupus nephritis: association with vitamin D and chemokine C-X-C motif ligand 12. Youssry S; Hussein A; Moaaz M Microbiol Immunol; 2021 Sep; 65(9):392-399. PubMed ID: 34081342 [TBL] [Abstract][Full Text] [Related]
27. Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. Braun NA; Celada LJ; Herazo-Maya JD; Abraham S; Shaginurova G; Sevin CM; Grutters J; Culver DA; Dworski R; Sheller J; Massion PP; Polosukhin VV; Johnson JE; Kaminski N; Wilkes DS; Oswald-Richter KA; Drake WP Am J Respir Crit Care Med; 2014 Sep; 190(5):560-71. PubMed ID: 25073001 [TBL] [Abstract][Full Text] [Related]
28. PD-L1 Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A Front Immunol; 2018; 9():2241. PubMed ID: 30327652 [No Abstract] [Full Text] [Related]
29. PD-1-expressing B cells suppress CD4 Wang X; Wang G; Wang Z; Liu B; Han N; Li J; Lu C; Liu X; Zhang Q; Yang Q; Wang G Mol Immunol; 2019 May; 109():20-26. PubMed ID: 30851633 [TBL] [Abstract][Full Text] [Related]
30. Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma. Shimauchi T; Kabashima K; Nakashima D; Sugita K; Yamada Y; Hino R; Tokura Y Int J Cancer; 2007 Dec; 121(12):2585-90. PubMed ID: 17721918 [TBL] [Abstract][Full Text] [Related]
31. Increased percentages of PD-1 on CD4+ T cells is associated with higher INF-γ production and altered IL-17 production in patients with systemic lupus erythematosus. Dolff S; Quandt D; Feldkamp T; Jun C; Mitchell A; Hua F; Specker C; Kribben A; Witzke O; Wilde B Scand J Rheumatol; 2014; 43(4):307-13. PubMed ID: 25088926 [TBL] [Abstract][Full Text] [Related]
32. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells. Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999 [TBL] [Abstract][Full Text] [Related]
33. Reduced Tolerogenic Program Death-Ligand 1-Expressing Conventional Type 1 Dendritic Cells Are Associated with Rapid Decline in Chronic Obstructive Pulmonary Disease. Chen KY; Sun WL; Wu SM; Feng PH; Lin CF; Chen TT; Lu YH; Ho SC; Chen YH; Lee KY Cells; 2024 May; 13(10):. PubMed ID: 38786101 [TBL] [Abstract][Full Text] [Related]
34. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus. Bertsias GK; Nakou M; Choulaki C; Raptopoulou A; Papadimitraki E; Goulielmos G; Kritikos H; Sidiropoulos P; Tzardi M; Kardassis D; Mamalaki C; Boumpas DT Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915 [TBL] [Abstract][Full Text] [Related]
35. Serum levels of soluble programmed death-1 (sPD-1) and soluble programmed death ligand 1(sPD-L1) in systemic lupus erythematosus: Association with activity and severity. Du Y; Nie L; Xu L; Wu X; Zhang S; Xue J Scand J Immunol; 2020 Jul; 92(1):e12884. PubMed ID: 32243638 [TBL] [Abstract][Full Text] [Related]
37. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684 [TBL] [Abstract][Full Text] [Related]
38. Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus. Gao N; Dresel J; Eckstein V; Gellert R; Störch H; Venigalla RK; Schwenger V; Max R; Blank N; Lorenz HM; Tretter T Arthritis Rheumatol; 2014 Oct; 66(10):2849-61. PubMed ID: 24942956 [TBL] [Abstract][Full Text] [Related]
39. Generation of Human Breg-Like Phenotype with Regulatory Function In Vitro with Bacteria-Derived Oligodeoxynucleotides. Gallego-Valle J; Pérez-Fernández VA; Correa-Rocha R; Pion M Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895745 [TBL] [Abstract][Full Text] [Related]
40. High programmed death 1 expression on T cells in aplastic anemia. Zhao W; Zhang Y; Zhang P; Yang J; Zhang L; He A; Zhang W; Hideto T Immunol Lett; 2017 Mar; 183():44-51. PubMed ID: 28153603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]